RT Journal Article
SR Electronic
T1 The CAR-T Therapy Tisagenlecleucel Is Safe in Secondary CNS Lymphoma
JF Cancer Discovery
JO Cancer Discov
FD American Association for Cancer Research
SP OF11
OP OF11
DO 10.1158/2159-8290.CD-RW2019-116
VO 9
IS 9
YR 2019
UL http://cancerdiscovery.aacrjournals.org/content/9/9/OF11.abstract
AB Tisagenlecleucel has an acceptable safety profile and showed preliminary evidence of CNS efficacy.